ECOG Trial Outcomes in Smoldering Myeloma

ECOG Trial Outcomes in Smoldering Myeloma
Don Photo

Don
3 anos 28 Visualizações
Categoria:
Descrição:
Robert Rifkin, MD, McKesson Biosimilars, Associate Chair, Rocky Mountain Cancer Centers discusses the outcomes from the ECOD trial in smoldering multiple myeloma (MM).